Influence of partial unfolding and aggregation of human stefin B (cystatin B) EPM1 mutants G50E and Q71P on selective cleavages by cathepsins B and S

References

Alvarez-Fernandez, M., Barrett, A.J., Gerhartz, B., Dando, P.M., Ni, J., and Abrahamson, M. (1999). Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J. Biol. Chem. 274, 19195–19203.10.1074/jbc.274.27.19195Search in Google Scholar PubMed

Barrett, A.J., Kembhavi, A.A., Brown, M.A., Kirschke, H., Knight, C.G., Tamai, M., and Hanada, K. (1982). l-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem. J. 201, 189–198.10.1042/bj2010189Search in Google Scholar PubMed PubMed Central

Berkovic, S.F., Andermann, F., Carpenter, S., and Wolfe, L.S. (1986). Progressive myoclonus epilepsies: specific causes and diagnosis. N. Engl. J. Med. 315, 296–305.10.1056/NEJM198607313150506Search in Google Scholar PubMed

Bird, P.I., Trapani, J.A., and Villadangos, J.A. (2009). Endolysosomal proteases and their inhibitors in immunity. Nat. Rev. Immunol. 9, 871–882.10.1038/nri2671Search in Google Scholar PubMed

Ceru, S., Kokalj, S.J., Rabzelj, S., Skarabot, M., Gutierrez-Aguirre, I., Kopitar-Jerala, N., Anderluh, G., Turk, D., Turk, V., and Zerovnik, E. (2008). Size and morphology of toxic oligomers of amyloidogenic proteins: a case study of human stefin B. Amyloid 15, 147–159.10.1080/13506120802193555Search in Google Scholar PubMed

Ceru, S., Layfield, R., Zavasnik-Bergant, T., Repnik, U., Kopitar-Jerala, N., Turk, V., and Zerovnik, E. (2010). Intracellular aggregation of human stefin B: confocal and electron microscopy study. Biol. Cell 102, 319–334.10.1042/BC20090163Search in Google Scholar PubMed

Cipollini, E., Riccio, M., Di Giaimo, R., Dal Piaz, F., Pulice, G., Catania, S., Caldarelli, I., Dembic, M., Santi, S., and Melli, M. (2008). Cystatin B and its EPM1 mutants are polymeric and aggregate prone in vivo. Biochim. Biophys. Acta 1783, 312–322.10.1016/j.bbamcr.2007.08.007Search in Google Scholar PubMed

Cohen, N.R., Hammans, S.R., Macpherson, J., and Nicoll, J.A. (2011). New neuropathological findings in Unverricht-Lundborg disease: neuronal intranuclear and cytoplasmic inclusions. Acta Neuropathol. 121, 421–427.10.1007/s00401-010-0738-2Search in Google Scholar PubMed

Dahl, S.W., Halkier, T., Lauritzen, C., Dolenc, I., Pedersen, J., Turk, V., and Turk, B. (2001). Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing. Biochemistry 40, 1671–1678.10.1021/bi001693zSearch in Google Scholar PubMed

Droga-Mazovec, G., Bojic, L., Petelin, A., Ivanova, S., Romih, R., Repnik, U., Salvesen, G.S., Stoka, V., Turk, V., and Turk, B. (2008). Cysteine cathepsins trigger caspase-dependent cell death through cleavage of Bid and antiapoptotic Bcl-2 homologues. J. Biol. Chem. 283, 19140–19150.10.1074/jbc.M802513200Search in Google Scholar PubMed

Eldridge, R., Iivanainen, M., Stern, R., Koerber, T., and Wilder, B.J. (1983). “Baltic” myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet 2, 838–842.10.1016/S0140-6736(83)90749-3Search in Google Scholar

Franceschetti, S., Sancini, G., Buzzi, A., Zucchini, S., Paradiso, B., Magnaghi, G., Frassoni, C., Chikhladze, M., Avanzini, G., and Simonato, M. (2007). A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression. Neurobiol. Dis. 25, 675–685.10.1016/j.nbd.2006.11.006Search in Google Scholar

Haltia, M., Kristensson, K., and Sourander, P. (1969). Neuropathological studies in three Scandinavian cases of progressive myoclonus epilepsy. Acta Neurol. Scand. 45, 63–77.10.1111/j.1600-0404.1969.tb01220.xSearch in Google Scholar

Hamilton, G., Colbert, J.D., Schuettelkopf, A.W., and Watts, C. (2008). Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis. EMBO J. 27, 499–508.10.1038/sj.emboj.7601979Search in Google Scholar

Jerala, R., Trstenjak, M., Lenarcic, B., and Turk, V. (1988). Cloning a synthetic gene for human stefin B and its expression in E. coli. FEBS Lett. 239, 41–44.10.1016/0014-5793(88)80541-6Search in Google Scholar

Joensuu, T., Kuronen, M., Alakurtti, K., Tegelberg, S., Hakala, P., Aalto, A., Huopaniemi, L., Aula, N., Michellucci, R., Eriksson, K., et al. (2007). Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients. Eur. J. Hum. Genet. 15, 185–193.10.1038/sj.ejhg.5201723Search in Google Scholar PubMed

Joensuu, T., Lehesjoki, A.E., and Kopra, O. (2008). Molecular background of EPM1-Unverricht-Lundborg disease. Epilepsia 49, 557–563.10.1111/j.1528-1167.2007.01422.xSearch in Google Scholar PubMed

Kopitar, G., Dolinar, M., Strukelj, B., Pungercar, J., and Turk, V. (1996). Folding and activation of human procathepsin S from inclusion bodies produced in Escherichia coli. Eur. J. Biochem. 236, 558–562.10.1111/j.1432-1033.1996.00558.xSearch in Google Scholar PubMed

Kordis, D. and Turk, V. (2009). Phylogenomic analysis of the cystatin superfamily in eukaryotes and prokaryotes. BMC Evol. Biol. 9, 266.10.1186/1471-2148-9-266Search in Google Scholar PubMed PubMed Central

Koskenkorva, P., Hypponen, J., Aikia, M., Mervaala, E., Kiviranta, T., Eriksson, K., Lehesjoki, A.E., Vanninen, R., and Kalviainen, R. (2011). Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene. Neurodegener. Dis. 8, 515–522.10.1159/000323470Search in Google Scholar PubMed

Koskiniemi, M., Donner, M., Majuri, H., Haltia, M., and Norio, R. (1974). Progressive myoclonus epilepsy. A clinical and histopathological study. Acta Neurol. Scand. 50, 307–332.10.1111/j.1600-0404.1974.tb02782.xSearch in Google Scholar

Kuhelj, R., Dolinar, M., Pungercar, J., and Turk, V. (1995). The preparation of catalytically active human cathepsin B from its precursor expressed in Escherichia coli in the form of inclusion bodies. Eur. J. Biochem. 229, 533–539.10.1111/j.1432-1033.1995.0533k.xSearch in Google Scholar

Lalioti, M.D., Scott, H.S., Buresi, C., Rossier, C., Bottani, A., Morris, M.A., Malafosse, A., and Antonarakis, S.E. (1997a). Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 386, 847–851.10.1038/386847a0Search in Google Scholar

Lalioti, M.D., Mirotsou, M., Buresi, C., Peitsch, M.C., Rossier, C., Ouazzani, R., Baldy-Moulinier, M., Bottani, A., Malafosse, A., and Antonarakis, S.E. (1997b). Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1). Am. J. Hum. Genet. 60, 342–351.Search in Google Scholar

Lehtinen, M.K., Tegelberg, S., Schipper, H., Su, H., Zukor, H., Manninen, O., Kopra, O., Joensuu, T., Hakala, P., Bonni, A., et al. (2009). Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1. J. Neurosci. 29, 5910–5915.10.1523/JNEUROSCI.0682-09.2009Search in Google Scholar

Lenarcic, B., Krizaj, I., Zunec, P., and Turk, V. (1996). Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases. FEBS Lett. 395, 113–118.10.1016/0014-5793(96)00984-2Search in Google Scholar

Nagler, D.K., Storer, A.C., Portaro, F.C., Carmona, E., Juliano, L., and Menard, R. (1997). Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. Biochemistry 36, 12608–12615.10.1021/bi971264+Search in Google Scholar

Pennacchio, L.A., Lehesjoki, A.E., Stone, N.E., Willour, V.L., Virtaneva, K., Miao, J., D’Amato, E., Ramirez, L., Faham, M., Koskiniemi, M., et al. (1996). Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271, 1731–1734.10.1126/science.271.5256.1731Search in Google Scholar

Popovic, T., Cimerman, N., Dolenc, I., Ritonja, A., and Brzin, J. (1999). Cathepsin L is capable of truncating cystatin C of 11 N-terminal amino acids. FEBS Lett. 455, 92–96.10.1016/S0014-5793(99)00824-8Search in Google Scholar

Rabzelj, S., Turk, V., and Zerovnik, E. (2005). In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1. Protein Sci. 14, 2713–2722.10.1110/ps.051609705Search in Google Scholar PubMed PubMed Central

Repnik, U., Stoka, V., Turk, V., and Turk, B. (2012). Lysosomes and lysosomal cathepsins in cell death. Biochim. Biophys. Acta 1824, 22–33.10.1016/j.bbapap.2011.08.016Search in Google Scholar PubMed

Tizon, B., Sahoo, S., Yu, H., Gauthier, S., Kumar, A.R., Mohan, P., Figliola, M., Pawlik, M., Grubb, A., Uchiyama, Y., et al. (2010). Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines. PLoS One 5, e9819.10.1371/journal.pone.0009819Search in Google Scholar

Turk, V. and Bode, W. (1991). The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 285, 213–219.10.1016/0014-5793(91)80804-CSearch in Google Scholar

Turk, V., Brzin, J., Kotnik, M., Lenarcic, B., Popovic, T., Ritonja, A., Trstenjak, M., Begic-Odobasic, L., and Machleidt, W. (1986). Human cysteine proteinases and their protein inhibitors stefins, cystatins and kininogens. Biomed. Biochim. Acta 45, 1375–1384.Search in Google Scholar

Turk, V., Stoka, V., and Turk, D. (2008). Cystatins: biochemical and structural properties, and medical relevance. Front. Biosci. 13, 5406–5420.10.2741/3089Search in Google Scholar PubMed

Turk, V., Stoka, V., Vasiljeva, O., Renko, M., Sun, T., Turk, B., and Turk, D. (2012). Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim. Biophys. Acta 1824, 68–88.10.1016/j.bbapap.2011.10.002Search in Google Scholar PubMed PubMed Central

Yang, F., Tay, K.H., Dong, L., Thorne, R.F., Jiang, C.C., Yang, E., Tseng, H.Y., Liu, H., Christopherson, R., Hersey, P., et al. (2010). Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIP(L) from degradation by the E3 ligase itch in human melanoma cells. Cell Death Differ. 17, 1354–1367.10.1038/cdd.2010.29Search in Google Scholar PubMed

Zerovnik, E. and Kopitar Jerala, N. (2006). Human stefins and cystatins. New York: Nova Biomedical Books.Search in Google Scholar